- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1204EUR$1,250USD£1,036GBP
- Report
- March 2024
- 200 Pages
Global
From €3999EUR$4,150USD£3,440GBP
- Report
- August 2022
- 119 Pages
Global
From €4336EUR$4,500USD£3,730GBP
- Report
- June 2018
- 162 Pages
Global
From €10595EUR$10,995USD£9,113GBP
- Report
- May 2024
- 50 Pages
Global
From €2554EUR$2,650USD£2,197GBP
- Report
- April 2023
- 147 Pages
Global
From €5781EUR$5,999USD£4,972GBP
Ganciclovir is an antiviral drug used to treat infections caused by certain types of viruses. It is primarily used to treat cytomegalovirus (CMV) infections, which can cause serious complications in people with weakened immune systems, such as those with HIV/AIDS or those who have had an organ transplant. Ganciclovir is also used to treat other viral infections, such as herpes simplex virus (HSV) and varicella zoster virus (VZV).
Ganciclovir is available in both oral and intravenous formulations. It is typically administered as a prophylactic to prevent CMV infections in people with weakened immune systems, and as a treatment for active CMV infections. Ganciclovir is also used to treat HSV and VZV infections, although it is not as effective as other antiviral drugs for these infections.
Ganciclovir is marketed by several pharmaceutical companies, including GlaxoSmithKline, Merck, and Novartis. It is also available as a generic drug in some countries. Show Less Read more
